TipRanksTop Financial ExpertsInsidersChristopher Ryan Sullivan

Christopher Ryan Sullivan Insider Profile

4 Followers
Christopher Ryan Sullivan, CFO at Avalo Therapeutics, holds 6.00 shares in Avalo Therapeutics (Ticker: AVTX).
tipranks
Christopher Ryan Sullivan

Christopher Ryan Sullivan
Avalo Therapeutics (AVTX)
CFO

Not Ranked
Christopher Ryan Sullivan has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$47
100.00%
A breakdown of Christopher Ryan Sullivan's holdings

Insider Roles

Avalo Therapeutics
(AVTX)
CFO
Roles that Christopher Ryan Sullivan holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Christopher Ryan Sullivan

Christopher Ryan Sullivan's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Avalo Therapeutics
Jun 13, 2023
CFO
Uninformative Buy
1.75K
$46.56
Christopher Ryan Sullivan has not reported any informative transactions for AVTX, therefore, performance cannot be measured.
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jun 11, 2020
Uninformative Buy
$6.71K
-
$2.27
Dec 14, 2021
Uninformative Buy
$1.50K
-
$1.57
Jun 13, 2023
Uninformative Buy
$1.75K
-
$3.42
List of latest transactions for each holding click on a transaction to see Christopher Ryan Sullivan's performance on stock

Christopher Ryan Sullivan insider profile FAQ

What is the percentage of profitable transactions made by Christopher Ryan Sullivan?
The percentage of profitable transactions made by Christopher Ryan Sullivan is ―.
    What is the average return per transaction made by Christopher Ryan Sullivan?
    The average return per transaction made by Christopher Ryan Sullivan is ―.
      What stocks does Christopher Ryan Sullivan hold?
      Christopher Ryan Sullivan holds: AVTX stocks.
        What was Christopher Ryan Sullivan’s latest transaction?
        Christopher Ryan Sullivan latest transaction was an Uninformative Buy of $1.75K.
          What was Christopher Ryan Sullivan's most profitable transaction?
          Christopher Ryan Sullivan’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Christopher Ryan Sullivan's role in Avalo Therapeutics?
            Christopher Ryan Sullivan's role in Avalo Therapeutics is CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.